Novel phosphocholines containing DHEA were synthesized. The antiproliferative activities of the novel phosphatidylcholines were studied. Incorporating DHEA at the sn-1 or sn-2 position reduces drug toxicity against normal cells (Balb/3T3). B16 and HL-60 cell lines were most sensitive to the tested phospholipids.